Background: While primary care systematically offers conventional cardiovascular risk assessment, genetic tests for coronary heart disease (CHD) are increasingly commercially available to patients. It is unclear how individuals may respond to these new sources of risk information.\ud \ud Aim: To explore how patients who have had a recent conventional cardiovascular risk assessment, perceive additional information from genetic testing for CHD.\ud \ud Design and setting: Qualitative interview study in 12 practices in Nottinghamshire from both urban and rural settings.\ud \ud Method: Interviews were conducted with 29 adults, who consented to genetic testing after having had a conventional cardiovascular risk assessment.\ud \ud Results: Individ...
Introduction: 23andMe provides consumers the opportunity to receive genetic information without invo...
Background: Hypertrophic Cardiomyopathy (HCM) a relatively common inherited cardiac disease, sympto...
Background: The health economic evidence about the value and optimal targeting of genetic testing in...
Background: While primary care systematically offers conventional cardiovascular risk assessment, ge...
Aim: This study assesses the feasibility of collecting genetic samples and self-reported outcome mea...
Inherited cardiac conditions (ICCs) can lead to sudden cardiac death at any age, yet are often asymp...
Abstract Background UK and US policy initiatives have suggested that, in the future, patients and cl...
BACKGROUND: Individuals routinely receive information about their risk of coronary heart disease (CH...
The underlying genetic etiologies for a group of conditions known as inherited cardiac disease are b...
Inherited cardiac conditions (ICCs) can lead to sudden cardiac death at any age, yet are often asymp...
Background: Familial hypercholesterolaemia (FH) is a common inherited condition causing elevated cho...
Expectations are high that increasing knowledge of the genetic basis of cardiovascular disease will ...
Background: Scientific knowledge on genetics is growing fast, resulting in farreaching implications ...
According to the World Health Organization (2005), cardiovascular disease (CVD) is the number one ca...
Coronary artery disease (CAD) is progressive, and early intervention can prevent the progression to ...
Introduction: 23andMe provides consumers the opportunity to receive genetic information without invo...
Background: Hypertrophic Cardiomyopathy (HCM) a relatively common inherited cardiac disease, sympto...
Background: The health economic evidence about the value and optimal targeting of genetic testing in...
Background: While primary care systematically offers conventional cardiovascular risk assessment, ge...
Aim: This study assesses the feasibility of collecting genetic samples and self-reported outcome mea...
Inherited cardiac conditions (ICCs) can lead to sudden cardiac death at any age, yet are often asymp...
Abstract Background UK and US policy initiatives have suggested that, in the future, patients and cl...
BACKGROUND: Individuals routinely receive information about their risk of coronary heart disease (CH...
The underlying genetic etiologies for a group of conditions known as inherited cardiac disease are b...
Inherited cardiac conditions (ICCs) can lead to sudden cardiac death at any age, yet are often asymp...
Background: Familial hypercholesterolaemia (FH) is a common inherited condition causing elevated cho...
Expectations are high that increasing knowledge of the genetic basis of cardiovascular disease will ...
Background: Scientific knowledge on genetics is growing fast, resulting in farreaching implications ...
According to the World Health Organization (2005), cardiovascular disease (CVD) is the number one ca...
Coronary artery disease (CAD) is progressive, and early intervention can prevent the progression to ...
Introduction: 23andMe provides consumers the opportunity to receive genetic information without invo...
Background: Hypertrophic Cardiomyopathy (HCM) a relatively common inherited cardiac disease, sympto...
Background: The health economic evidence about the value and optimal targeting of genetic testing in...